Loading provider…
Loading provider…
Hematology & Oncology Physician in Anniston, AL
NPI: 1548203235Primary Employer
Oncology Specialties, P.C.
clearviewcancer.com
HQ Phone
Mobile
Get MD Robert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 625 | 1,984 |
| 2 | 80053Blood test, comprehensive group of blood chemicals | 614 | 1,789 |
| 3 | 36415Insertion of needle into vein for collection of blood sample | 607 | 1,918 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 359 | 738 |
| 5 | 82728Ferritin (blood protein) level | 299 | 481 |
Pathological complete response after neoadjuvant pembrolizumab and radiation.
Authors: Carlo Contreras, Jennifer De Los Santos
Journal: Clin Exp Dermatol
Publication Date: 2018-11-07
A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases.
Authors: John Fiveash, Sharon Spencer, Ruby Meredith, Barton Guthrie
Journal: Adv Radiat Oncol
Publication Date: 2016-04-01
Correlates of response and outcomes with talimogene laherperpvec.
Lead Sponsor: Replimune Inc.
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: BIOLOGICAL: RP1, BIOLOGICAL: nivolumab
Lead Sponsor: Elios Therapeutics, LLC
Collaborators: LumaBridge
Intervention / Treatment: DRUG: TLPLDC Vaccine
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Cetuximab, DRUG: Avelumab